COX
The cyclooxygenase (COX) enzymes have elaborate roles in human physiology and pathology, spanning the cardiovascular, neuronal, renal, immune, gastrointestinal and reproductive systems.The cyclooxygenase isoenzymes, COX-1 and COX-2, catalyze the formation of prostaglandins, thromboxane, and levuloglandins. COX enzymes are clinically important because they are inhibited by aspirin and numerous other non-steroidal anti-inflammatory drugs. COX-2 induction involves the orchestration of membrane-to-nucleus signaling processes such as tyrosine kinases, protein kinase C isoforms, peroxisome proliferator activated receptor, ras, NF-kB, and other transcription factors. Many of these converge on the mitogen activated protein kinase (MAPK) pathway involved in the transcriptional regulation of inflammatory genes. High expression of COX-2 in many tumors derives, in part, from somatic mutations that persistently activate signaling pathways for COX-2 expression.
References
1.Fitzpatrick FA. Curr Pharm Des. 2004;10(6):577-88.
References
1.Fitzpatrick FA. Curr Pharm Des. 2004;10(6):577-88.
Chromatin/Epigenetic
COX
-
(+)-Catechin pentaacetate
catalog no : M37765
cas no: 16198-01-9
(+)-Catechin pentaacetate (Catechin pentaacetate) is an esterified derivative of catechin with the potential to improve intestinal morphology and function and positively modulate the microbiome, and reduce iron and zinc transport proteins in the duodenum. -
TNF/IFNγ-IN-1
catalog no : M37330
cas no: 876013-29-5
TNF/IFNγ-IN-1 (TGA) is a dual inhibitor of TNF and IFN-γ. TNF/IFNγ-IN-1 has potential antioxidant and anti-inflammatory activities for neurodegenerative diseases such as Alzheimer. -
hCYP3A4 Fluorogenic substrate 1
catalog no : M37062
cas no: 186299-00-3
hCYP3A4 Fluorogenic substrate 1, a phthalimide derivative, exhibits low activity against COX. -
COX-2-IN-34
catalog no : M36994
cas no: 2788578-71-0
COX-2-IN-34 is a selective, orally potent COX-2 inhibitor that shows anti-inflammatory activity without gastric ulcer toxicity during experiments in mice. -
Feladilimab
catalog no : M36892
cas no: 2252518-85-5
Feladilimab (GSK3359609) is an IgG4 monoclonal antibody that is an ICOS agonist.